基本信息
浏览量:17
职业迁徙
个人简介
Our mission is to make fundamental discoveries relating to hormone signaling, transcriptional control and host-pathogen interactions. We leverage these discoveries to pursue drug design as treatments for viral infections and chronic inflammatory diseases. We use a range of sophisticated biological techniques including cryo-electron microscopy, x-ray crystallography, mass spectrometry, deep mutational scanning and in silico simulations. Our primary research interests include lipid-mediated signaling and transport, development of LRH-1 modulators to treat metabolic disease, characterization of anti-inflammatory steroids and molecular evolution. With the outbreak of SARS-CoV-2, we were well-placed to redirect our expertise to investigate detection and neutralizing antibodies using Cryo-EM, and to predict antibody escape using deep mutational scanning (DMS). Working closely with the RADx initiative, our methods have proven useful to multiple companies seeking FDA approval for their novel COVID-19 diagnostic methods. Currently we are expanding our technology to tackle other arising infectious diseases of concern.
研究兴趣
论文共 204 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nature metabolismno. 5 (2024): 963-979
Alejandro Soto-Avellaneda,Alexandra E Oxford, Fabio Halla, Peyton Vasquez, Emily Oe, Anton D Pugel, Alyssa M Schoenfeld,Matthew C Tillman, André Cuevas,Eric A Ortlund,Brad E Morrison
Eric Ortlund,Chih-Yu Chen,Kristal Maner-Smith,Manoj Khadka, Jun Ahn, Xueyun Gulbin,Anna Ivanova,Eric Dammer,Nicholas Seyfried,David Bennett,Ihab Hajjar
Research square (2024)
Helaina E. Huneault,Chih-Yu Chen,Catherine C. Cohen, Xueyun Liu,Zachery R. Jarrell,Zhulin He, Karla E. Desantos,Jean A. Welsh,Kristal M. Maner-Smith,Eric A. Ortlund,Jeffrey B. Schwimmer,Miriam B. Vos
PHYSIOLOGYno. S1 (2023)
NUCLEIC ACIDS RESEARCHno. 17 (2023): 9507-9507
引用0浏览0引用
0
0
HEPATOLOGY (2023): S819-S819
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn